|
1 hit(s) found in 0.08 seconds Search term: FTBJKONNNSKOLX-XUDSTZEEBD Found by InChIKey (full match)
Please
login
to be able to add spectra, identifiers, links and publications.
|
|
|
ChemSpider ID: |
59638
|
|
Empirical Formula: |
C21H32O2
|
|
Molecular Weight: |
316.4776
|
|
Nominal Mass: |
316
Da
|
|
Average Mass: |
316.4776
Da
|
|
Monoisotopic Mass: |
316.24023
Da
|
|
|
|
Systematic Name: |
(8R,9S,10R,13S,14S,17S)-13,17-diethyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
|
|
SMILES: |
O=C4\C=C3/[C@@H]([C@H]2CC[C@]1([C@@H](CC[C@@]1(O)CC)[C@@H]2CC3)CC)CC4
|
|
InChI: |
InChI=1/C21H32O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h13,16-19,23H,3-12H2,1-2H3/t16-,17+,18+,19-,20-,21-/m0/s1
|
|
InChIKey: |
FTBJKONNNSKOLX-XUDSTZEEBD
|
|
Std. InChI: |
InChI=1S/C21H32O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h13,16-19,23H,3-12H2,1-2H3/t16-,17+,18+,19-,20-,21-/m0/s1
|
|
Std. InChIKey: |
FTBJKONNNSKOLX-XUDSTZEESA-N
|
Norbolethone ( Genabol) is an anabolic steroid. It was first developed in 1966 by Wyeth Laboratories, and tested for use as an agent to encourage weight gain and for the treatment of short stature, but was never marketed commercially because of fears that it might be toxic. It subsequently showed up in urine tests on athletes in competition in the early 2000s.
Norbolethone was found to have been brought to the market by the chemist Patrick Arnold, of the Bay Area Laboratory Co-operative (BALCO), an American nutritional supplement company. It is reputed to have been the active ingredient in the original formulation of the "undetectable" steroid formulation known as "The Clear" before being replaced by the more potent drug tetrahydrogestrinone.
In 2002, Don Catlin, MD, the founder and then-director of the UCLA Olympic Analytical Lab and now head of the Los Angeles-based nonprofit Anti-Doping Research, identified for the first time in an athlete’s urine sample norbolethone, the first reported "designer" anabolic steroid. In the same year, U.S. bicycle racer Tammy Thomas was caught using it and was banned from her sport.
Read more... or Edit at Wikipedia...
Validated by Experts, Validated by Users, Non-Validated, Removed by Users,
Redirected by Users, Redirect Approved by Experts
(8R,9S,10R,13S,14S,17S)-13,17-Diethyl-17-hydroxy-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one (non-preferred name)
18,19-Dinor-17.alpha.-pregn-4-en-3-one, 13-ethyl-17-hydroxy-
18,19-Dinorpregn-4-en-3-one, 13-ethyl-17-hydroxy-, (17.alpha.)-
3-Ethyl-17-hydroxy-18,19-dinorpregn-4-en-3-one
dl-13b,17a-Diethyl-17b-hydroxygon-4-en-3-one
Gon-4-en-3-one, 13.beta.,17.alpha.-diethyl-17-hydroxy-
Norboletone
(.+-.)-13-Ethyl-17-hydroxy-18,19-dinor-17.alpha.-pregn-4-en-3-one
(+-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha -pregn-4-en-3-one
(+-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-3-one
More...
1235-15-0
[RN]
18,19-Dinor-17-alpha-pregn-4-en-3-one, 13-ethyl-17-hydroxy-
18,19-Dinor-17-alpha-pregn-4-en-3-one, 13-ethyl-17-hydroxy-, (+-)-
18,19-Dinorpregn-4-en-3-one, 13-ethyl-17-hydroxy-, (17alpha)-, (+-)-
797-58-0
[RN]
dl-13-beta,17-alpha-Diethyl-17-beta-hydroxygon-4-en-3-one
DL-Norbolethone
Genabol
Gon-4-en-3-one, 13beta,17alpha-diethyl-17-hydroxy-
Norbalethone
norbolethone
Norbolethone (13beta,17alpha-diethyl-17beta-hydroxygon-4-en-3-one)
Norbolethone [USAN]
Norbolethone CUSAN
Less...
Validated by Experts, Validated by Users, Non-Validated, Removed by Users,
Redirected by Users, Redirect Approved by Experts
|
ACD/LogP: |
4.60
|
# of Rule of 5 Violations: |
0
|
|
ACD/LogD (pH 5.5): |
4.6
|
ACD/LogD (pH 7.4): |
4.6
|
|
ACD/BCF (pH 5.5): |
1844.17
|
ACD/BCF (pH 7.4): |
1844.17
|
|
ACD/KOC (pH 5.5): |
7572.83
|
ACD/KOC (pH 7.4): |
7572.83
|
|
#H bond acceptors: |
2
|
#H bond donors: |
1
|
|
#Freely Rotating Bonds: |
3
|
Polar Surface Area: |
26.3
Å2
|
|
Index of Refraction: |
1.551
|
Molar Refractivity: |
92.37
cm3
|
|
Molar Volume: |
289.4
cm3
|
Polarizability: |
36.62
10-24cm3
|
|
Surface Tension: |
43.6
dyne/cm
|
Density: |
1.09
g/cm3
|
|
Flash Point: |
195.6
°C
|
Enthalpy of Vaporization: |
83.05
kJ/mol
|
|
Boiling Point: |
459.5
°C at 760 mmHg
|
Vapour Pressure: |
2.24E-10
mmHg at 25°C
|
Log Octanol-Water Partition Coef (SRC):
Log Kow (KOWWIN v1.67 estimate) = 4.25
Boiling Pt, Melting Pt, Vapor Pressure Estimations (MPBPWIN v1.42):
Boiling Pt (deg C): 407.81 (Adapted Stein & Brown method)
Melting Pt (deg C): 157.38 (Mean or Weighted MP)
VP(mm Hg,25 deg C): 4.82E-009 (Modified Grain method)
Subcooled liquid VP: 1.09E-007 mm Hg (25 deg C, Mod-Grain method)
Water Solubility Estimate from Log Kow (WSKOW v1.41):
Water Solubility at 25 deg C (mg/L): 7.441
log Kow used: 4.25 (estimated)
no-melting pt equation used
Water Sol Estimate from Fragments:
Wat Sol (v1.01 est) = 4.6446 mg/L
ECOSAR Class Program (ECOSAR v0.99h):
Class(es) found:
Vinyl/Allyl Ketones
Henrys Law Constant (25 deg C) [HENRYWIN v3.10]:
Bond Method : 6.22E-009 atm-m3/mole
Group Method: Incomplete
Henrys LC [VP/WSol estimate using EPI values]: 2.698E-010 atm-m3/mole
Log Octanol-Air Partition Coefficient (25 deg C) [KOAWIN v1.10]:
Log Kow used: 4.25 (KowWin est)
Log Kaw used: -6.595 (HenryWin est)
Log Koa (KOAWIN v1.10 estimate): 10.845
Log Koa (experimental database): None
Probability of Rapid Biodegradation (BIOWIN v4.10):
Biowin1 (Linear Model) : 0.2358
Biowin2 (Non-Linear Model) : 0.0046
Expert Survey Biodegradation Results:
Biowin3 (Ultimate Survey Model): 2.0531 (months )
Biowin4 (Primary Survey Model) : 3.0620 (weeks )
MITI Biodegradation Probability:
Biowin5 (MITI Linear Model) : 0.3370
Biowin6 (MITI Non-Linear Model): 0.0642
Anaerobic Biodegradation Probability:
Biowin7 (Anaerobic Linear Model): -1.2073
Ready Biodegradability Prediction: NO
Hydrocarbon Biodegradation (BioHCwin v1.01):
Structure incompatible with current estimation method!
Sorption to aerosols (25 Dec C)[AEROWIN v1.00]:
Vapor pressure (liquid/subcooled): 1.45E-005 Pa (1.09E-007 mm Hg)
Log Koa (Koawin est ): 10.845
Kp (particle/gas partition coef. (m3/ug)):
Mackay model : 0.206
Octanol/air (Koa) model: 0.0172
Fraction sorbed to airborne particulates (phi):
Junge-Pankow model : 0.882
Mackay model : 0.943
Octanol/air (Koa) model: 0.579
Atmospheric Oxidation (25 deg C) [AopWin v1.92]:
Hydroxyl Radicals Reaction:
OVERALL OH Rate Constant = 110.2765 E-12 cm3/molecule-sec
Half-Life = 0.097 Days (12-hr day; 1.5E6 OH/cm3)
Half-Life = 1.164 Hrs
Ozone Reaction:
OVERALL Ozone Rate Constant = 7.393750 E-17 cm3/molecule-sec
Half-Life = 0.155 Days (at 7E11 mol/cm3)
Half-Life = 3.720 Hrs
Fraction sorbed to airborne particulates (phi): 0.912 (Junge,Mackay)
Note: the sorbed fraction may be resistant to atmospheric oxidation
Soil Adsorption Coefficient (PCKOCWIN v1.66):
Koc : 5353
Log Koc: 3.729
Aqueous Base/Acid-Catalyzed Hydrolysis (25 deg C) [HYDROWIN v1.67]:
Rate constants can NOT be estimated for this structure!
Bioaccumulation Estimates from Log Kow (BCFWIN v2.17):
Log BCF from regression-based method = 2.574 (BCF = 374.6)
log Kow used: 4.25 (estimated)
Volatilization from Water:
Henry LC: 6.22E-009 atm-m3/mole (estimated by Bond SAR Method)
Half-Life from Model River: 1.675E+005 hours (6977 days)
Half-Life from Model Lake : 1.827E+006 hours (7.612E+004 days)
Removal In Wastewater Treatment:
Total removal: 42.58 percent
Total biodegradation: 0.42 percent
Total sludge adsorption: 42.16 percent
Total to Air: 0.00 percent
(using 10000 hr Bio P,A,S)
Level III Fugacity Model:
Mass Amount Half-Life Emissions
(percent) (hr) (kg/hr)
Air 0.0318 1.43 1000
Water 11.9 1.44e+003 1000
Soil 81.5 2.88e+003 1000
Sediment 6.55 1.3e+004 0
Persistence Time: 1.87e+003 hr
Descriptors:
0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 1, 2, 30, 0, 0, 1, 0, 0, 1, 1, 2, 0, 0, 0
| Category | Target | PDB Code | LASSO Score |
| Nuclear Hormone Receptors | MR, mineralocorticoid receptor | 2aa2 | 0.88 |
| Nuclear Hormone Receptors | AR, androgen receptor | 1xq2 | 0.42 |
| Nuclear Hormone Receptors | ER, estrogen receptor; agonist | 1l2i | 0.41 |
| Nuclear Hormone Receptors | PR, progesterone receptor | 1sr7 | 0.28 |
| Nuclear Hormone Receptors | GR, glucocorticoid receptor | 1m2z | 0.10 |
| Metalloenzymes | ACE, angiotensin-converting enzyme | 1o86 | 0.03 |
| Nuclear Hormone Receptors | RXRa, retinoic X receptor R | 1mvc | 0.03 |
| Nuclear Hormone Receptors | PPARg, peroxisome proliferator activated receptor | 1fm9 | 0.02 |
| Kinases | SRC, tyrosine kinase SRC | 2src | 0.01 |
| Other Enzymes | HMGR, hydroxymethylglutaryl-CoA reductase | 1hw8 | 0.01 |
| Serine Proteases | Thrombin | 1ba8 | 0.01 |
| Other Enzymes | HIVPR, HIV protease | 1hpx | 0.01 |
| Metalloenzymes | PDE5, phosphodiesterase 5 | 1xp0 | 0.01 |
| Other Enzymes | PARP, poly(ADP-ribose) polymerase | 1efy | 0.01 |
| Nuclear Hormone Receptors | ER, estrogen receptor; antagonist | 3ert | 0.01 |
| Other Enzymes | PNP, purine nucleoside phosphorylase | 1b8o | 0.00 |
| Other Enzymes | InhA, enoyl ACP reductase | 1p44 | 0.00 |
| Other Enzymes | AmpC, AmpC beta-lactamase | 1xgj | 0.00 |
| Folate Enzymes | DHFR, dihydrofolate reductase | 3dfr | 0.00 |
| Other Enzymes | HIVRT, HIV reverse transcriptase | 1rt1 | 0.00 |
| Other Enzymes | NA, neuraminidase | 1a4g | 0.00 |
| Serine Proteases | Trypsin | 1bju | 0.00 |
| Kinases | VEGFr2, vascular endothelial growth factor receptor | 1vr2 | 0.00 |
| Other Enzymes | GPB, glycogen phosphorylase | 1a8i | 0.00 |
| Other Enzymes | SAHH, S-adenosyl-homocysteine hydrolase | 1a7a | 0.00 |
| Metalloenzymes | ADA, adenosine deaminase | 1stw | 0.00 |
| Kinases | FGFr1, fibroblast growth factor receptor kinase | 1agw | 0.00 |
| Other Enzymes | COX-2, cyclooxygenase-2 | 1cx2 | 0.00 |
| Metalloenzymes | COMT, catechol O-methyltransferase | 1h1d | 0.00 |
| Other Enzymes | ALR2, aldose reductase | 1ah3 | 0.00 |
| Kinases | CDK2, cyclindependent kinase 2 | 1ckp | 0.00 |
| Kinases | TK, thymidine kinase | 1kim | 0.00 |
| Other Enzymes | COX-1, cyclooxygenase-1 | 1p4g | 0.00 |
| Kinases | P38 MAP, P38 mitogen activated protein | 1kv2 | 0.00 |
| Folate Enzymes | GART, glycinamide ribonucleotide transformylase | 1c2t | 0.00 |
| Kinases | PDGFrb, platelet derived growth factor receptor kinase | N/A | 0.00 |
| Kinases | HSP90, human heat shock protein 90 | 1uy6 | 0.00 |
| Other Enzymes | AChE, acetylcholinesterase | 1eve | 0.00 |
| Kinases | EGFr, epidermal growth factor receptor | 1m17 | 0.00 |
| Serine Proteases | FXa, factor Xa | 1f0r | 0.00 |
|
|